Leukemia is very challenging to treat. But with two new discoveries, it can now be screened and managed at an earlier time.
Thanks to regenerative medicine, the accelerated mutation of blood cancer cells can now be augmented via bone marrow or stem cell transplantation.
Acceleron Pharma's CMO resigns despite company claims of a strong outlook for a cancer wonder drug.
Hemogenyx Pharmaceuticals Ltd. will start trading on the London Stock Exchange under the ticker symbol HEMO on Thursday, October 5, 2017.